Table 2.
OR | 95% CI | P value | aOR* | 95% CI | P value | |
All patients | ||||||
Disease duration, years | 1.072 | 0.999 to 1.149 | 0.052 | |||
Triple-positive aPLs | 4.758 | 1.016 to 22.276 | 0.048 | 11.662 | 2.117 to 64.243 | 0.005 |
Hypocomplementemia | 7.682 | 1.444 to 40.875 | 0.017 | 9.047 | 1.530 to 53.495 | 0.015 |
Arterial thrombosis subgroup | ||||||
Triple-positive aPLs | 24.167 | 2.724 to 214.369 | 0.004 | NA | ||
Venous thrombosis subgroup | ||||||
Hypocomplementemia | 13.073 | 1.421 to 120.255 | 0.023 | 7.966 | 0.788 to 80.552 | 0.079 |
PAPS subgroup | ||||||
Premature birth <34 weeks | 21.599 | 1.247 to 374.179 | 0.035 | NA | ||
Triple-positive aPLs | 36.195 | 2.037 to 643.120 | 0.015 | NA | ||
Hypocomplementemia | 25.738 | 1.725 to 383.955 | 0.018 | NA |
Data on IQR or n (%).
*aOR (adjustment for low-dose aspirin and hydroxychloroquine).
aOR, adjusted OR; aPLs, antiphospholipid antibodies; NA, not applicable; OAPS, obstetric antiphospholipid syndrome; PAPS, primary antiphospholipid syndrome.